secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001493152-24-024632
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma raises $41K via convertible note with 35% discount conversion
-------------------------------------------------------------------------------

- Issued $49,200 convertible promissory note to 1800 Diagonal Lending LLC for $41,000, net proceeds for working capital.
- Note bears 15% one-time interest, maturity April 15, 2025, with five scheduled payments totaling $56,580.
- Conversion price set at 65% of lowest trading price over 10 prior trading days (35% discount) upon event of default.
- Investor is accredited; note issued under Section 4(a)(2) and Regulation D exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/0001493152-24-024632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer